Article Details

Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent set to advance in top drug sales

Retrieved on: 2024-09-29 20:13:27

Tags for this article:

Click the tags to see associated articles and topics

Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent set to advance in top drug sales. View article details on hiswai:

Excerpt

AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and Regeneron/Sanofi Dupixent ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up